CELL SOURCE INC by Cell Source, Inc. (CLCS) Stock Price, Quote, News & History

CLCSOTCPK

Trade with Public

$0.8200

At close: May 15, 5:00 PM EST

$0.6832

-0.14-16.68%

After Hours: Feb 26, 9:01 AM EST

OverviewShort Interest

Key Statistics

Open

Volume / Avg.

0 / 4.30K

Day Range

- - -

52 Wk Range

0.18 - 2.25

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.4

Recent Cell Source Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.68M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

2.74M

Free Cash Flow (TTM)

-2.68M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

52.43K

Valuation Metrics

Enterprise Value

$65.71M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-17.07%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.27

Company Debt

Total Debt

$10.07M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$74.63K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$12.50K

Key Statistics

Open

Volume / Avg.

0 / 4.30K

Day Range

- - -

52 Wk Range

0.18 - 2.25

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.4

About

Sector

Health Care

Industry

Biotechnology

Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercialize...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CELL SOURCE INC by Cell Source, Inc. (CLCS) stock?

You can purchase shares of CELL SOURCE INC by Cell Source, Inc. (OTCPK:CLCS) through any online brokerage.

View our list of the best stock brokerages

Who are CELL SOURCE INC by Cell Source, Inc. (CLCS) competitors?

There are no as such competitors for CELL SOURCE INC by Cell Source, Inc..

What is the forecast, or price target, for CELL SOURCE INC by Cell Source, Inc. (CLCS) stock?

There is no analysis for CELL SOURCE INC by Cell Source, Inc. to provide a consensus price target.

What is the current price for CELL SOURCE INC by Cell Source, Inc. (CLCS)?

The stock price for CELL SOURCE INC by Cell Source, Inc. (OTCPK: CLCS) is $0.82 last updated May 11, 2026 at 9:30 AM EDT.

Does CELL SOURCE INC by Cell Source, Inc. (CLCS) pay a dividend?

There are no upcoming dividends for CELL SOURCE INC by Cell Source, Inc..

When is CELL SOURCE INC by Cell Source, Inc. (OTCPK:CLCS) reporting earnings?

CELL SOURCE INC by Cell Source, Inc. does not have any upcoming earnings scheduled.

Is CELL SOURCE INC by Cell Source, Inc. (CLCS) going to split?

There is no upcoming split for CELL SOURCE INC by Cell Source, Inc..

What sector and industry does CELL SOURCE INC by Cell Source, Inc. (CLCS) operate in?

CELL SOURCE INC by Cell Source, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.